Related Experiment Videos
Expression of human mucous proteinase inhibitor in respiratory tract: a study by in situ hybridization
I Van Seuningen1, J P Audie, B Gosselin
1Unité 377 INSERM, l'Hôpital Calmette, Lille, France.
Abstract:
Human mucous proteinase inhibitor (MPI) is present in bronchial secretions, where it participates in the protection of lung structures against degradation by leukocyte elastase. The protein has been localized by immunohistochemical studies and immunogold labeling essentially in the serous cells of the submucosal glands and also in the surface epithelial cells of central and peripheral airways. However, until now no gene expression study has been performed at the tissue level. In this study, in situ hybridization was used to precisely study MPI mRNA expression in bronchial tissue sections with a specific radiolabeled oligonucleotide probe. By light microscopy, MPI gene expression was localized exclusively in the serous and seromucinous acini of the submucosal glands of large airways. The MPI gene was expressed in submucosal glands of normal and carcinomatous tissue sections, whereas it was not expressed in bronchial and bronchiolar surface epithelia.
Insights
Human mucous proteinase inhibitor (MPI) gene expression is found in submucosal glands of the airways, not surface epithelia. This study precisely located MPI mRNA in lung tissue, revealing its specific glandular localization.
Area of Science:
- Pulmonary Medicine
- Molecular Biology
- Protease Inhibitors
Background:
- Human mucous proteinase inhibitor (MPI) protects lung structures from leukocyte elastase in bronchial secretions.
- Previous studies localized MPI protein to airway submucosal gland serous cells and surface epithelia using immunohistochemistry.
- Gene expression at the tissue level for MPI remained uncharacterized.
Purpose of the Study:
- To precisely determine the tissue-level gene expression of Human mucous proteinase inhibitor (MPI) in bronchial tissues.
- To investigate the cellular localization of MPI mRNA within the airways.
Main Methods:
- In situ hybridization utilizing a specific radiolabeled oligonucleotide probe.
- Light microscopy for precise localization of MPI mRNA signal.
- Analysis of both normal and carcinomatous bronchial tissue sections.
Main Results:
- MPI gene expression was exclusively localized to the serous and seromucinous acini of submucosal glands in large airways.
- MPI mRNA was detected in submucosal glands of both normal and cancerous lung tissues.
- No MPI gene expression was observed in the bronchial and bronchiolar surface epithelia.
Conclusions:
- The study precisely mapped MPI mRNA expression to submucosal glands in the airways.
- MPI gene expression occurs in these glands irrespective of normal or cancerous tissue status.
- This finding clarifies the cellular source of MPI in the airways, differentiating it from surface epithelial cells.